Deutsche Bank’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $262K | Sell |
77,048
-16,906
| -18% | -$57.5K | ﹤0.01% | 2805 |
|
|
2025
Q1 | $377K | Sell |
93,954
-9,228
| -9% | -$37K | ﹤0.01% | 2607 |
|
|
2024
Q4 | $670K | Buy |
103,182
+36,542
| +55% | +$237K | ﹤0.01% | 2439 |
|
|
2024
Q3 | $369K | Buy |
66,640
+9,725
| +17% | +$53.9K | ﹤0.01% | 2583 |
|
|
2024
Q2 | $318K | Sell |
56,915
-10,241
| -15% | -$57.1K | ﹤0.01% | 2535 |
|
|
2024
Q1 | $451K | Buy |
67,156
+1,552
| +2% | +$10.4K | ﹤0.01% | 2371 |
|
|
2023
Q4 | $598K | Sell |
65,604
-1,258
| -2% | -$11.5K | ﹤0.01% | 2252 |
|
|
2023
Q3 | $369K | Buy |
66,862
+15,811
| +31% | +$87.3K | ﹤0.01% | 2343 |
|
|
2023
Q2 | $436K | Sell |
51,051
-24,043
| -32% | -$205K | ﹤0.01% | 2430 |
|
|
2023
Q1 | $690K | Buy |
75,094
+18,637
| +33% | +$171K | ﹤0.01% | 2306 |
|
|
2022
Q4 | $576K | Buy |
56,457
+4,790
| +9% | +$48.9K | ﹤0.01% | 2360 |
|
|
2022
Q3 | $761K | Sell |
51,667
-5,725
| -10% | -$84.3K | ﹤0.01% | 2138 |
|
|
2022
Q2 | $616K | Buy |
57,392
+2,808
| +5% | +$30.1K | ﹤0.01% | 2464 |
|
|
2022
Q1 | $588K | Buy |
54,584
+44,165
| +424% | +$476K | ﹤0.01% | 2637 |
|
|
2021
Q4 | $170K | Buy |
10,419
+543
| +5% | +$8.86K | ﹤0.01% | 3419 |
|
|
2021
Q3 | $212K | Buy |
+9,876
| New | +$212K | ﹤0.01% | 3507 |
|